FY2025 Annual Report

Reporting period: 2025.01.01-2025.12.31

Summary: HUA MEDICINE-B (02552) reported Revenue of 492.93M(+92.63%); Operating profit of 1.11B(+561.42%); Net profit attributable to owners of 1.11B(+542.29%).

ReportedYoY
Prior YearYoY
RevenueUp YoY
492.93M92.63%
255.89M234.02%
Operating profitUp YoY
1.11B561.42%
-241.53M18.79%
Net profit attributable to ownersUp YoY
1.11B542.29%
-250.14M18.42%

Revenue

ReportedUnit: CNY

Operating profit

ReportedUnit: CNY

Net profit attributable to owners

ReportedUnit: CNY

Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.

About this page

This page shows HUA MEDICINE-B (02552) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect